BioSpace News Archive

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“the Company” or “RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration, announced today that the first patient has been enrolled in ARISE-3, a phase 3 clinical trial sponsored by ReGenTree LLC

The global Addison’s disease therapeutics market is expected to post a CAGR of close to 4% during the period 2019-2023, according to the latest market research report by Technavio.

MiraMed Global Services, Inc., a leader in healthcare revenue cycle management services and business process outsourcing solutions, announces it has completed its merger with Medac, Inc., a leading provider of anesthesia revenue cycle management.

Heart disease is the leading killer among women, but it does not have to be.

Dendreon Pharmaceuticals, a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy, signed a long-term lease agreement to maintain its corporate headquarters and immunotherapy manufacturing facility (IMF) in Seal Beach

This year’s annual meeting is held in New Orleans and is a gathering of the most prestigious society of rhinoplasty surgeons in the world.

Previous analysis demonstrated robust and statistically significant clinical benefits of the drug in moderate to severe knee OA.

Partnership with St. Louis’s Danforth Center seeks to accelerate technologies that advance the U.S. agriculture industry

Today, Food Allergy Research & Education (FARE), the world’s leading food allergy advocacy organization and the largest private funder of food allergy research, kicked off Food Allergy Awareness Week 2019 by lighting the Empire State Building teal to raise awareness of food allergies, a growing public health crisis.

NEO Welcomes Fourth Cannabis-focused SPAC